ID   DDX23_HUMAN             Reviewed;         820 AA.
AC   Q9BUQ8; B2R600; B4DH15; O43188;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 3.
DT   28-JUN-2023, entry version 196.
DE   RecName: Full=Probable ATP-dependent RNA helicase DDX23 {ECO:0000305};
DE            EC=3.6.4.13 {ECO:0000305};
DE   AltName: Full=100 kDa U5 snRNP-specific protein;
DE   AltName: Full=DEAD box protein 23;
DE   AltName: Full=PRP28 homolog;
DE   AltName: Full=U5-100kD;
GN   Name=DDX23 {ECO:0000312|HGNC:HGNC:17347};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 272-290;
RP   409-419 AND 433-441, SUBCELLULAR LOCATION, PHOSPHORYLATION, AND
RP   IDENTIFICATION IN U5 AND U5/4/6 SNRNP COMPLEXES.
RX   PubMed=9409622;
RA   Teigelkamp S., Mundt C., Achsel T., Will C.L., Luehrmann R.;
RT   "The human U5 snRNP-specific 100-kD protein is an RS domain-containing,
RT   putative RNA helicase with significant homology to the yeast splicing
RT   factor Prp28p.";
RL   RNA 3:1313-1326(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Amygdala, and Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE SPLICEOSOMAL
RP   C COMPLEX.
RX   PubMed=11991638; DOI=10.1017/s1355838202021088;
RA   Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J.;
RT   "Purification and characterization of native spliceosomes suitable for
RT   three-dimensional structural analysis.";
RL   RNA 8:426-439(2002).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   SUBUNIT.
RX   PubMed=16723661; DOI=10.1261/rna.55406;
RA   Liu S., Rauhut R., Vornlocher H.-P., Luehrmann R.;
RT   "The network of protein-protein interactions within the human U4/U6.U5 tri-
RT   snRNP.";
RL   RNA 12:1418-1430(2006).
RN   [9]
RP   FUNCTION, AND PHOSPHORYLATION BY SRPK2.
RX   PubMed=18425142; DOI=10.1038/nsmb.1415;
RA   Mathew R., Hartmuth K., Moehlmann S., Urlaub H., Ficner R., Luehrmann R.;
RT   "Phosphorylation of human PRP28 by SRPK2 is required for integration of the
RT   U4/U6-U5 tri-snRNP into the spliceosome.";
RL   Nat. Struct. Mol. Biol. 15:435-443(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH ERBB4, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=20858735; DOI=10.1158/1541-7786.mcr-10-0042;
RA   Gilmore-Hebert M., Ramabhadran R., Stern D.F.;
RT   "Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage
RT   response pathways.";
RL   Mol. Cancer Res. 8:1388-1398(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND SER-16, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; SER-107 AND SER-109, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   INTERACTION WITH ERCC6.
RX   PubMed=26030138; DOI=10.1371/journal.pone.0128558;
RA   Nicolai S., Filippi S., Caputo M., Cipak L., Gregan J., Ammerer G.,
RA   Frontini M., Willems D., Prantera G., Balajee A.S., Proietti-De-Santis L.;
RT   "Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group
RT   B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin
RT   Dynamics.";
RL   PLoS ONE 10:E0128558-E0128558(2015).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND PHOSPHORYLATION.
RX   PubMed=28076779; DOI=10.1016/j.celrep.2016.12.050;
RA   Sridhara S.C., Carvalho S., Grosso A.R., Gallego-Paez L.M.,
RA   Carmo-Fonseca M., de Almeida S.F.;
RT   "Transcription Dynamics Prevent RNA-Mediated Genomic Instability through
RT   SRPK2-Dependent DDX23 Phosphorylation.";
RL   Cell Rep. 18:334-343(2017).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-686 AND LYS-811, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Involved in pre-mRNA splicing and its phosphorylated form (by
CC       SRPK2) is required for spliceosomal B complex formation
CC       (PubMed:18425142). Independently of its spliceosome formation function,
CC       required for the suppression of incorrect R-loops formed during
CC       transcription; R-loops are composed of a DNA:RNA hybrid and the
CC       associated non-template single-stranded DNA (PubMed:28076779).
CC       {ECO:0000269|PubMed:18425142, ECO:0000269|PubMed:28076779}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13;
CC         Evidence={ECO:0000305};
CC   -!- SUBUNIT: The phosphorylated form (by SRPK2) is a component of the
CC       U4/U6-U5 tri-snRNP complex composed of the U4, U6 and U5 snRNAs and at
CC       least PRPF3, PRPF4, PRPF6, PRPF8, PRPF31, SNRNP200, TXNL4A, WDR57,
CC       SNRNP40, DDX23, CD2BP2, PPIH, SNU13, EFTUD2, SART1 and USP39
CC       (PubMed:16723661, PubMed:9409622). Identified in the spliceosome C
CC       complex (PubMed:11991638). Interacts with ERBB4 (PubMed:20858735).
CC       Interacts with ERCC6 (PubMed:26030138). {ECO:0000269|PubMed:11991638,
CC       ECO:0000269|PubMed:16723661, ECO:0000269|PubMed:20858735,
CC       ECO:0000269|PubMed:26030138, ECO:0000269|PubMed:9409622}.
CC   -!- INTERACTION:
CC       Q9BUQ8; Q96DI7: SNRNP40; NbExp=2; IntAct=EBI-540096, EBI-538492;
CC       Q9BUQ8; P54274: TERF1; NbExp=2; IntAct=EBI-540096, EBI-710997;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20858735,
CC       ECO:0000269|PubMed:28076779, ECO:0000269|PubMed:9409622}. Chromosome
CC       {ECO:0000269|PubMed:28076779}. Note=During transcription, accumulates
CC       at chromatin loci where unscheduled R-loops form and colocalizes with
CC       paused 'Ser-5'-phosphorlyated POLR2A/RNA polymerase II and kinase
CC       SRPK2. {ECO:0000269|PubMed:28076779}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BUQ8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BUQ8-2; Sequence=VSP_056575, VSP_056576;
CC   -!- PTM: In vitro phosphorylated by CLK1 and U1 snRNP-associated protein
CC       kinase (PubMed:9409622). Phosphorylated by SRPK2 and this
CC       phosphorylation is required for its association with the tri-snRNP
CC       (U4/U6-U5 tri-small nuclear ribonucleoproteins) and subsequent
CC       spliceosomal B complex formation (PubMed:18425142). May be
CC       phosphorylated by SRPK2 on Ser residues in the SR domain; the
CC       phosphorylation is required for the removal of inappropriate R-loops
CC       during transcription (PubMed:28076779). {ECO:0000269|PubMed:18425142,
CC       ECO:0000269|PubMed:28076779, ECO:0000269|PubMed:9409622}.
CC   -!- SIMILARITY: Belongs to the DEAD box helicase family. DDX23/PRP28
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF026402; AAB87902.1; -; mRNA.
DR   EMBL; AK294877; BAG57976.1; -; mRNA.
DR   EMBL; AK312379; BAG35297.1; -; mRNA.
DR   EMBL; AC117498; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471111; EAW58011.1; -; Genomic_DNA.
DR   EMBL; BC002366; AAH02366.1; -; mRNA.
DR   CCDS; CCDS8770.1; -. [Q9BUQ8-1]
DR   RefSeq; NP_004809.2; NM_004818.2. [Q9BUQ8-1]
DR   PDB; 3JCR; EM; 7.00 A; F=1-820.
DR   PDB; 4NHO; X-ray; 2.00 A; A=338-820.
DR   PDB; 6AH0; EM; 5.70 A; X=1-820.
DR   PDB; 6QW6; EM; 2.92 A; 5X=1-820.
DR   PDB; 6QX9; EM; 3.28 A; 5X=1-820.
DR   PDBsum; 3JCR; -.
DR   PDBsum; 4NHO; -.
DR   PDBsum; 6AH0; -.
DR   PDBsum; 6QW6; -.
DR   PDBsum; 6QX9; -.
DR   AlphaFoldDB; Q9BUQ8; -.
DR   SMR; Q9BUQ8; -.
DR   BioGRID; 114811; 463.
DR   ComplexPortal; CPX-2391; U4/U6.U5 small nuclear ribonucleoprotein complex.
DR   CORUM; Q9BUQ8; -.
DR   DIP; DIP-34974N; -.
DR   IntAct; Q9BUQ8; 73.
DR   MINT; Q9BUQ8; -.
DR   STRING; 9606.ENSP00000310723; -.
DR   GlyGen; Q9BUQ8; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9BUQ8; -.
DR   MetOSite; Q9BUQ8; -.
DR   PhosphoSitePlus; Q9BUQ8; -.
DR   SwissPalm; Q9BUQ8; -.
DR   BioMuta; DDX23; -.
DR   DMDM; 160385708; -.
DR   EPD; Q9BUQ8; -.
DR   jPOST; Q9BUQ8; -.
DR   MassIVE; Q9BUQ8; -.
DR   MaxQB; Q9BUQ8; -.
DR   PaxDb; Q9BUQ8; -.
DR   PeptideAtlas; Q9BUQ8; -.
DR   ProteomicsDB; 4180; -.
DR   ProteomicsDB; 79121; -. [Q9BUQ8-1]
DR   Antibodypedia; 13695; 216 antibodies from 24 providers.
DR   DNASU; 9416; -.
DR   Ensembl; ENST00000308025.8; ENSP00000310723.2; ENSG00000174243.11. [Q9BUQ8-1]
DR   Ensembl; ENST00000547135.5; ENSP00000446770.1; ENSG00000174243.11. [Q9BUQ8-2]
DR   GeneID; 9416; -.
DR   KEGG; hsa:9416; -.
DR   MANE-Select; ENST00000308025.8; ENSP00000310723.2; NM_004818.3; NP_004809.2.
DR   UCSC; uc001rsm.4; human. [Q9BUQ8-1]
DR   AGR; HGNC:17347; -.
DR   CTD; 9416; -.
DR   DisGeNET; 9416; -.
DR   GeneCards; DDX23; -.
DR   HGNC; HGNC:17347; DDX23.
DR   HPA; ENSG00000174243; Low tissue specificity.
DR   MIM; 612172; gene.
DR   neXtProt; NX_Q9BUQ8; -.
DR   OpenTargets; ENSG00000174243; -.
DR   PharmGKB; PA134934941; -.
DR   VEuPathDB; HostDB:ENSG00000174243; -.
DR   eggNOG; KOG0333; Eukaryota.
DR   GeneTree; ENSGT00940000155606; -.
DR   HOGENOM; CLU_003041_11_0_1; -.
DR   InParanoid; Q9BUQ8; -.
DR   OMA; KKFNFEW; -.
DR   OrthoDB; 5487240at2759; -.
DR   PhylomeDB; Q9BUQ8; -.
DR   TreeFam; TF300527; -.
DR   PathwayCommons; Q9BUQ8; -.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72165; mRNA Splicing - Minor Pathway.
DR   SignaLink; Q9BUQ8; -.
DR   SIGNOR; Q9BUQ8; -.
DR   BioGRID-ORCS; 9416; 675 hits in 1166 CRISPR screens.
DR   ChiTaRS; DDX23; human.
DR   GeneWiki; DDX23; -.
DR   GenomeRNAi; 9416; -.
DR   Pharos; Q9BUQ8; Tbio.
DR   PRO; PR:Q9BUQ8; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q9BUQ8; protein.
DR   Bgee; ENSG00000174243; Expressed in calcaneal tendon and 199 other tissues.
DR   ExpressionAtlas; Q9BUQ8; baseline and differential.
DR   Genevisible; Q9BUQ8; HS.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IDA:UniProtKB.
DR   GO; GO:0000785; C:chromatin; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0046540; C:U4/U6 x U5 tri-snRNP complex; IDA:MGI.
DR   GO; GO:0005682; C:U5 snRNP; IDA:HGNC-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003724; F:RNA helicase activity; TAS:Reactome.
DR   GO; GO:0000354; P:cis assembly of pre-catalytic spliceosome; IC:HGNC-UCL.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0062176; P:R-loop processing; IDA:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
DR   GO; GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB.
DR   CDD; cd17945; DEADc_DDX23; 1.
DR   CDD; cd18787; SF2_C_DEAD; 1.
DR   DisProt; DP02332; -.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000629; RNA-helicase_DEAD-box_CS.
DR   InterPro; IPR014014; RNA_helicase_DEAD_Q_motif.
DR   PANTHER; PTHR47958; ATP-DEPENDENT RNA HELICASE DBP3; 1.
DR   PANTHER; PTHR47958:SF56; RNA HELICASE; 1.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00039; DEAD_ATP_HELICASE; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   PROSITE; PS51195; Q_MOTIF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Chromosome;
KW   Direct protein sequencing; Helicase; Hydrolase; Isopeptide bond;
KW   mRNA processing; mRNA splicing; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Spliceosome; Ubl conjugation.
FT   CHAIN           1..820
FT                   /note="Probable ATP-dependent RNA helicase DDX23"
FT                   /id="PRO_0000055128"
FT   DOMAIN          422..627
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          651..799
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   REGION          1..244
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           391..419
FT                   /note="Q motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00552"
FT   MOTIF           549..552
FT                   /note="DEAD box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   COMPBIAS        1..40
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        41..61
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        62..244
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         435..442
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         16
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         109
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   CROSSLNK        686
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        811
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         107..108
FT                   /note="SL -> RH (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056575"
FT   VAR_SEQ         109..820
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056576"
FT   CONFLICT        137
FT                   /note="P -> L (in Ref. 1; AAB87902)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        281
FT                   /note="D -> E (in Ref. 1; AAB87902)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        309
FT                   /note="L -> F (in Ref. 1; AAB87902)"
FT                   /evidence="ECO:0000305"
FT   HELIX           357..359
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           362..364
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           367..377
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          379..385
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   TURN            393..395
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           400..409
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           416..425
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   TURN            426..428
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          431..434
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           441..455
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           458..461
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          470..474
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           478..492
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           493..495
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          499..502
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          504..506
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           508..516
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          520..524
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           526..534
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          545..550
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           551..556
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           560..567
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           572..574
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           580..583
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           585..593
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           595..597
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          601..607
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           611..620
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          625..629
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           635..638
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          639..645
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           648..650
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           651..660
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          667..670
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           674..686
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          691..693
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           704..712
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          717..720
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          734..740
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           745..752
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           753..755
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          757..760
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   STRAND          763..768
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           770..775
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           776..784
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           793..796
FT                   /evidence="ECO:0007829|PDB:4NHO"
FT   HELIX           799..801
FT                   /evidence="ECO:0007829|PDB:4NHO"
SQ   SEQUENCE   820 AA;  95583 MW;  01DD5BCF8BFBA2DB CRC64;
     MAGELADKKD RDASPSKEER KRSRTPDRER DRDRDRKSSP SKDRKRHRSR DRRRGGSRSR
     SRSRSKSAER ERRHKERERD KERDRNKKDR DRDKDGHRRD KDRKRSSLSP GRGKDFKSRK
     DRDSKKDEED EHGDKKPKAQ PLSLEELLAK KKAEEEAEAK PKFLSKAERE AEALKRRQQE
     VEERQRMLEE ERKKRKQFQD LGRKMLEDPQ ERERRERRER MERETNGNED EEGRQKIREE
     KDKSKELHAI KERYLGGIKK RRRTRHLNDR KFVFEWDASE DTSIDYNPLY KERHQVQLLG
     RGFIAGIDLK QQKREQSRFY GDLMEKRRTL EEKEQEEARL RKLRKKEAKQ RWDDRHWSQK
     KLDEMTDRDW RIFREDYSIT TKGGKIPNPI RSWKDSSLPP HILEVIDKCG YKEPTPIQRQ
     AIPIGLQNRD IIGVAETGSG KTAAFLIPLL VWITTLPKID RIEESDQGPY AIILAPTREL
     AQQIEEETIK FGKPLGIRTV AVIGGISRED QGFRLRMGCE IVIATPGRLI DVLENRYLVL
     SRCTYVVLDE ADRMIDMGFE PDVQKILEHM PVSNQKPDTD EAEDPEKMLA NFESGKHKYR
     QTVMFTATMP PAVERLARSY LRRPAVVYIG SAGKPHERVE QKVFLMSESE KRKKLLAILE
     QGFDPPIIIF VNQKKGCDVL AKSLEKMGYN ACTLHGGKGQ EQREFALSNL KAGAKDILVA
     TDVAGRGIDI QDVSMVVNYD MAKNIEDYIH RIGRTGRAGK SGVAITFLTK EDSAVFYELK
     QAILESPVSS CPPELANHPD AQHKPGTILT KKRREETIFA
//
